HomeEVGN • NASDAQ
Evogene Ltd
$0.75
Mar 28, 8:15:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$0.73
Day range
$0.73 - $0.77
Year range
$0.45 - $1.44
Market cap
37.67M USD
Avg Volume
251.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
578.00K-12.42%
Operating expense
7.81M91.47%
Net income
-6.60M-120.18%
Net profit margin
-1.14K-151.42%
Earnings per share
-0.13-85.71%
EBITDA
-6.96M-121.74%
Effective tax rate
0.05%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
31.06M-12.14%
Total assets
51.10M-8.95%
Total liabilities
22.42M5.06%
Total equity
28.68M
Shares outstanding
50.58M
Price to book
3.04
Return on assets
-35.04%
Return on capital
-56.99%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-6.60M-120.18%
Cash from operations
-5.92M-162.52%
Cash from investing
-586.00K-31.10%
Cash from financing
-147.00K58.71%
Net change in cash
-6.56M-127.74%
Free cash flow
-3.74M-153.76%
About
Evogene is a computational biology company based in Israel. Evogene Ltd. has developed a unique computational predictive biology "CPB" platform, which leverages big data with advanced algorithms such as machine learning and other artificial intelligence, while adding a deep understanding of biology and advanced biological technologies. Evogene is using its proprietary CPB platform to computationally design and develop next-generation life-science products based upon three core components: microbes, small molecules, and genetic elements. Evogene's computational platform allows it to substantially increase the probability of successful life-science product development, increase the efficiency and reduce the toxicity of its life-science products while reducing time and cost to development. Its strategic partners include BASF, Bayer, Corteva, ICL Group Ltd. as well as various academic and medical institutions. Wikipedia
Founded
2002
Employees
137
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu